+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Monkeypox Vaccine and Treatment Market Size, Share & Trends Analysis Report by Product (Vaccine, Drugs, Vaccinia Immune Globulin), by Gender, by Route of Administration, by End-use, by Region, and Segment Forecasts, 2022-2030

  • PDF Icon

    Report

  • 100 Pages
  • September 2022
  • Region: Global
  • Grand View Research
  • ID: 5665133
Description Jump to:
The global monkeypox vaccine and treatment market size is expected to reach USD 184.79 million by 2030, expanding at a CAGR of 10.16% from 2022 to 2030. The growing government initiatives for combating the monkeypox virus threat and a surge in awareness about the disease are the major factors driving the market. Moreover, an increase in R&D activities to develop vaccines and treatments is expected to fuel market growth.

The incidence rate of infection is higher in men as compared to women. According to the CDC’s data of August 2021, the monkeypox virus affected over 2,231 men of age 31 to 35 as compared to 11 women of age 31 to 35. The infection rate of the virus is more common in people between 20 to 50 years of age. Thus, the rising infection rates from the monkeypox virus are anticipated to fuel the demand for novel and effective treatment.

The increasing funding for boosting research activities and expanding manufacturing capacities of vaccine plants is likely to fuel market demand. For instance, in August 2022, the U.S. Department of Health and Human Services announced a funding of USD 11 million for providing support to fill and finish the manufacturing of JYNNEOS vaccine approved for preventing monkeypox and smallpox at GRAM, Michigan. This funding will assist GRAM to purchase extra equipment for JYNNEOS production.

Moreover, in July 2022, the pandemic institute awarded funding of around USD 580,049 to Liverpool researchers for managing the global threat of monkeypox. The funding is awarded for promoting research activities for understanding the stigma around the disease and developing new treatment regimens.

Furthermore, various strategic initiatives undertaken by the leading market players to strengthen their portfolio and market footprint are expected to facilitate market expansion. For instance, in August 2022, Bavarian Nordic A/S announced an agreement with Pan American Health Organization to boost equitable access to the Bavarian Nordic A/S monkeypox vaccine for countries in the Caribbean and Latin America. The vaccine delivery is likely to commence in the month of September.

In addition, in May 2022, SIGA Technologies, Inc. announced that its IV formulation TPOXX (tecovirimat) received U.S. FDA approval for the treatment of smallpox. The intravenous formulation is an alternative for patients who cannot swallow the oral formulation of the TPOXX. The IV formulation of TPOXX is also being used to manage the symptoms of monkeypox in the U.S.

However, the chances of side effects from the vaccine may hinder the market growth in the coming years. Some of the common side effects associated with the monkeypox vaccine include induration, muscle pain, swelling, nausea, and itching, among others.

Monkeypox Vaccine And Treatment Market Report Highlights

  • Based on product, the drugs segment held the largest share in 2022 owing to ongoing product approvals and increasing demand for antiviral drugs for the treatment
  • The male segment accounted for the largest share in 2022 due to the higher prevalence of infections among men
  • By route of administration, the oral segment dominated the market in 2022 due to the increased demand for oral antiviral drugs for the treatment of monkeypox disease
  • The hospitals segment was the largest segment in 2022. The specialty clinics segment is anticipated to register the fastest growth rate throughout the forecast period
  • Asia Pacific is expected to exhibit the fastest growth rate over the forecast period due to the increased risk of monkeypox infections and increasing awareness about vaccination

Table of Contents

Chapter 1 Methodology and Scope
1.1 Market Segmentation and Scope
1.1.1 Segment scope
1.1.2 Regional scope
1.1.3 Estimates and forecast timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased database:
1.3.2 Internal database
1.3.3 Secondary sources
1.3.4 Primary research
1.3.5 Details of primary research
1.4 Information or Data Analysis
1.4.1 Data analysis models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis
1.6.1.1 Approach: Commodity Flow Approach
1.7 Research Assumptions
1.8 List of Secondary Sources
1.9 List of Abbreviations
1.10 Objectives
1.10.1 Objective 1
1.10.2 Objective 2
1.10.3 Objective 3
1.10.4 Objective 4
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Competitive Insights
Chapter 3 Monkeypox Vaccine and Treatment Market Variables, Trends, & Scope
3.1 Market Lineage Outlook
3.1.1 Parent market
3.2 Market Dynamics
3.2.1 Market drivers analysis
3.2.1.1 Increase in prevalence of monkeypox infection
3.2.1.2 Government initiatives to combat outbreak of monkeypox
3.2.2 Market restraint analysis
3.2.2.1 Side effects associated with the vaccine and treatment
3.3 Penetration & Growth Prospect Mapping
3.4 Monkeypox Vaccine and Treatment: Market Analysis Tools
3.4.1 Industry analysis - Porter’s
3.4.2 PESTLE analysis
3.5 Regulatory Framework
3.6 Pricing Analysis
Chapter 4 Monkeypox Vaccine and Treatment Market Segment Analysis, By Product, 2022 - 2030 (USD Million)
4.1 Definition and Scope
4.2 Product Market Share Analysis, 2022 & 2030
4.3 Segment Dashboard
4.4 Global Monkeypox Vaccine and Treatment Market, by Product, 2022 to 2030
4.5 Market Size & Forecasts and Trend Analyses, 2022 to 2030
4.5.1 Vaccine
4.5.1.1 Vaccine market estimates and forecasts, 2022 - 2030 (USD Million)
4.5.1.1.1 JYNNEOS/Imvanex
4.5.1.1.1.1 JYNNEOS/Imvanex market estimates and forecasts, 2022 - 2030 (USD Million)
4.5.1.1.2 Smallpox Vaccine
4.5.1.1.2.1 Smallpox vaccine market estimates and forecasts, 2022 - 2030 (USD Million)
4.5.1.1.3 Others
4.5.1.1.3.1 Others market estimates and forecasts, 2022 - 2030 (USD Million)
4.5.2 Drugs
4.5.2.1 Drugs market estimates and forecasts, 2022 - 2030 (USD Million)
4.5.2.1.1 Tecovirimat
4.5.2.1.1.1 Tecovirimat market estimates and forecasts, 2022 - 2030 (USD Million)
4.5.2.1.2 Brincidofovir
4.5.2.1.2.1 Brincidofovir market estimates and forecasts, 2022 - 2030 (USD Million)
4.5.2.1.3 Cidofovir
4.5.2.1.3.1 Cidofovir market estimates and forecasts, 2022 - 2030 (USD Million)
4.5.2.1.4 Others
4.5.2.1.4.1 Others market estimates and forecasts, 2022 - 2030 (USD Million)
4.5.3 Vaccinia Immune Globulin (VIG)
4.5.3.1 Vaccinia Immune Globulin (VIG)market estimates and forecasts, 2022 - 2030 (USD Million)
Chapter 5 Monkeypox Vaccine and Treatment Market Segment Analysis, By Route of Administration2022 - 2030 (USD Million)
5.1 Definition and Scope
5.2 Route of Administration Market Share Analysis, 2022 & 2030
5.3 Segment Dashboard
5.4 Global Monkeypox Vaccine and Treatment Market, by Route of Administration, 2022 to 2030
5.5 Market Size & Forecasts and Trend Analyses, 2022 to 2030
5.5.1 Oral
5.5.1.1 Oral market estimates and forecasts, 2022 - 2030 (USD Million)
5.5.2 InjecTable
5.5.2.1 InjecTable market estimates and forecasts, 2022 - 2030 (USD Million)
Chapter 6 Monkeypox Vaccine and Treatment Market Segment Analysis, By Gender, 2022 - 2030 (USD Million)
6.1 Definition and Scope
6.2 Gender Market Share Analysis, 2022 & 2030
6.3 Segment Dashboard
6.4 Global Monkeypox Vaccine and Treatment Market, by Gender, 2022 to 2030
6.5 Market Size & Forecasts and Trend Analyses, 2022 to 2030
6.5.1 Male
6.5.1.1 Male market estimates and forecasts, 2022 - 2030 (USD Million)
6.5.2 Female
6.5.2.1 Female market estimates and forecasts, 2022 - 2030 (USD Million)
6.5.3 Others
6.5.3.1 Others market estimates and forecasts, 2022 - 2030 (USD Million)
Chapter 7 Monkeypox Vaccine and Treatment Market Segment Analysis, By End-use, 2022 - 2030 (USD Million)
7.1 Definition and Scope
7.2 End-use Market Share Analysis, 2022 & 2030
7.3 Segment Dashboard
7.4 Global Monkeypox Vaccine and Treatment Market, by End-use, 2022 to 2030
7.5 Market Size & Forecasts and Trend Analyses, 2022 to 2030
7.5.1 Hospitals
7.5.1.1 Hospitals market estimates and forecasts, 2022 - 2030 (USD Million)
7.5.2 Specialty Clinics
7.5.2.1 Specialty clinics market estimates and forecasts, 2022 - 2030 (USD Million)
7.5.3 Others
7.5.3.1 Others market estimates and forecasts, 2022 - 2030 (USD Million)
Chapter 8 Monkeypox Vaccine and Treatment Market Segment Analysis, By Region, 2022 - 2030 (USD Million)
8.1 Definition & Scope
8.2 Regional Market Share Analysis, 2022 & 2030
8.3 Regional Market Dashboard
8.4 Regional Market Snapshot
8.5 SWOT Analysis
8.5.1 North America
8.5.2 Europe
8.5.3 Asia Pacific
8.5.4 Latin America
8.5.5 Middle East and Africa
8.6 Market Size, & Forecasts, Revenue and Trend Analysis, 2022 to 2030
8.6.1 North America
8.6.1.1 North America market estimates and forecast, 2022-2030 (USD Million)
8.6.1.2 U.S.
8.6.1.2.1 U.S. monkeypox vaccine and treatment market estimates and forecasts, 2022 - 2030 (USD Million)
8.6.1.3 Canada
8.6.1.3.1 Canada monkeypox vaccine and treatment market estimates and forecasts, 2022 - 2030 (USD Million)
8.6.2 Europe
8.6.2.1 Europe monkeypox vaccine and treatment market estimates and forecasts, 2022 - 2030 (USD Million)
8.6.2.2 U.K.
8.6.2.2.1 U.K. monkeypox vaccine and treatment market estimates and forecasts, 2022 - 2030 (USD Million)
8.6.2.3 Germany
8.6.2.3.1 Germany monkeypox vaccine and treatment market estimates and forecasts, 2022 - 2030 (USD Million)
8.6.2.4 Spain
8.6.2.4.1 Spain monkeypox vaccine and treatment market estimates and forecasts, 2022 - 2030 (USD Million)
8.6.2.5 France
8.6.2.5.1 France monkeypox vaccine and treatment market estimates and forecasts, 2022 - 2030 (USD Million)
8.6.2.6 Italy
8.6.2.6.1 Italy monkeypox vaccine and treatment market estimates and forecasts, 2022 - 2030 (USD Million)
8.6.3 Asia Pacific
8.6.3.1 Asia Pacific monkeypox vaccine and treatment market estimates and forecasts, 2022 - 2030 (USD Million)
8.6.3.2 Japan
8.6.3.2.1 Japan monkeypox vaccine and treatment market estimates and forecasts, 2022 - 2030 (USD Million)
8.6.3.3 China
8.6.3.3.1 China monkeypox vaccine and treatment market estimates and forecasts, 2022 - 2030 (USD Million)
8.6.3.4 India
8.6.3.4.1 India monkeypox vaccine and treatment market estimates and forecasts, 2022 - 2030 (USD Million)
8.6.3.5 South Korea
8.6.3.5.1 South Korea monkeypox vaccine and treatment market estimates and forecasts, 2022 - 2030 (USD Million)
8.6.3.6 Australia
8.6.3.6.1 Australia monkeypox vaccine and treatment market estimates and forecasts, 2022 - 2030 (USD Million)
8.6.4 Latin America
8.6.4.1 Latin America monkeypox vaccine and treatment market estimates and forecasts, 2022 - 2030 (USD Million)
8.6.4.2 Brazil
8.6.4.2.1 Brazil monkeypox vaccine and treatment market estimates and forecasts, 2022 - 2030 (USD Million)
8.6.4.3 Mexico
8.6.4.3.1Mexico monkeypox vaccine and treatment market estimates and forecasts, 2022 - 2030 (USD Million)
8.6.4.4 Argentina
8.6.4.4.1 Argentina monkeypox vaccine and treatment market estimates and forecasts, 2022 - 2030 (USD Million)
8.6.5 MEA
8.6.5.1 MEA monkeypox vaccine and treatment market estimates and forecasts, 2022 - 2030 (USD Million)
8.6.5.2 South Africa
8.6.5.2.1 South Africa monkeypox vaccine and treatment market estimates and forecasts, 2022 - 2030 (USD Million)
8.6.5.3 Saudi Arabia
8.6.5.3.1 Saudi Arabia monkeypox vaccine and treatment market estimates and forecasts, 2022 - 2030 (USD Million)
8.6.5.4 UAE
8.6.5.4.1 UAE monkeypox vaccine and treatment market estimates and forecasts, 2022 - 2030 (USD Million)
Chapter 9 Monkeypox Vaccine and Treatment Market - Competitive Analysis
9.1 Recent Developments & Impact Analysis, by Key Market Participants
9.1.1 Ansoff matrix
9.1.2 Heat map analysis
9.1.3 Major Deals and Strategic Alliances Analysis
9.1.3.1 Joint Ventures
9.1.3.2 Licensing Agreements
9.1.3.3 Product Launches
9.1.3.4 Conferences and Campaigns
9.2 Company Categorization
9.2.1 Innovators
9.2.2 Market Leaders
9.3 Vendor Landscape
9.3.1 List of key distributors and channel partners
9.3.2 Key customers
9.4 Public Companies
9.4.1 Competitive Dashboard Analysis
9.4.1.1 Market Differentiators
9.5 Private Companies
9.5.1 List of key emerging companies
9.6 Company Profiles
9.6.1 Bavarian Nordic
9.6.1.1 Company overview
9.6.1.2 Financial performance
9.6.1.3 Product benchmarking
9.6.1.4 Strategic Initiatives
9.6.2 SIGA Technologies
9.6.2.1 Company overview
9.6.2.2 Financial performance
9.6.2.3 Product benchmarking
9.6.2.4 Strategic Initiatives
9.6.3 Chimerix
9.6.3.1 Company overview
9.6.3.2 Financial performance
9.6.3.3 Product benchmarking
9.6.3.4 Strategic Initiatives
9.6.4 EMERGENT
9.6.4.1 Company overview
9.6.4.2 Financial performance
9.6.4.3 Product benchmarking
9.6.4.4 Strategic Initiatives
9.6.5 Gilead Sciences, Inc.
9.6.5.1 Company overview
9.6.5.2 Financial performance
9.6.5.3 Product benchmarking
9.6.5.4 Strategic Initiatives
List of Tables
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Leading Market Players Anticipated to Witness Highest Growth
Table 4 Global Monkeypox Vaccine and Treatment Market, By Region, 2022 - 2030 (USD Million)
Table 5 Global Monkeypox Vaccine and Treatment Market, By Product, 2022 - 2030 (USD Million)
Table 6 Global Monkeypox Vaccine and Treatment Market, By Gender, 2022 - 2030 (USD Million)
Table 7 Global Monkeypox Vaccine and Treatment Market, By Route of Administration, 2022 - 2030 (USD Million)
Table 8 Global Monkeypox Vaccine and Treatment Market, By End-use, 2022 - 2030 (USD Million)
Table 9 North America Monkeypox Vaccine and Treatment Market, By Country, 2022 - 2030 (USD Million)
Table 10 North America Monkeypox Vaccine and Treatment Market, By Product, 2022 - 2030 (USD Million)
Table 11 North America Monkeypox Vaccine and Treatment Market, By Gender, 2022 - 2030 (USD Million)
Table 12 North America Monkeypox Vaccine and Treatment Market, By Route of Administration, 2022 - 2030 (USD Million)
Table 13 North America Monkeypox Vaccine and Treatment Market, By End-use, 2022 - 2030 (USD Million)
Table 14 U.S. Monkeypox Vaccine and Treatment Market, By Product, 2022 - 2030 (USD Million)
Table 15 U.S. Monkeypox Vaccine and Treatment Market, By Gender, 2022 - 2030 (USD Million)
Table 16 U.S. Monkeypox Vaccine and Treatment Market, By Route of Administration, 2022 - 2030 (USD Million)
Table 17 U.S. Monkeypox Vaccine and Treatment Market, By End-use, 2022 - 2030 (USD Million)
Table 18 Canada Monkeypox Vaccine and Treatment Market, By Product, 2022 - 2030 (USD Million)
Table 19 Canada Monkeypox Vaccine and Treatment Market, By Gender, 2022 - 2030 (USD Million)
Table 20 Canada Monkeypox Vaccine and Treatment Market, By Route of Administration, 2022 - 2030 (USD Million)
Table 21 Canada Monkeypox Vaccine and Treatment Market, By End-use, 2022 - 2030 (USD Million)
Table 22 Europe Monkeypox Vaccine and Treatment Market, By Country, 2022 - 2030 (USD Million)
Table 23 Europe Monkeypox Vaccine and Treatment Market, By Product, 2022 - 2030 (USD Million)
Table 24 Europe Monkeypox Vaccine and Treatment Market, By Gender, 2022 - 2030 (USD Million)
Table 25 Europe Monkeypox Vaccine and Treatment Market, By Route of Administration, 2022 - 2030 (USD Million)
Table 26 Europe Monkeypox Vaccine and Treatment Market, By End-use, 2022 - 2030 (USD Million)
Table 27 Germany Monkeypox Vaccine and Treatment Market, By Product, 2022 - 2030 (USD Million)
Table 28 Germany Monkeypox Vaccine and Treatment Market, By Gender, 2022 - 2030 (USD Million)
Table 29 Germany Monkeypox Vaccine and Treatment Market, By Route of Administration, 2022 - 2030 (USD Million)
Table 30 Germany Monkeypox Vaccine and Treatment Market, By End-use, 2022 - 2030 (USD Million)
Table 31 U.K. Monkeypox Vaccine and Treatment Market, By Product, 2022 - 2030 (USD Million)
Table 32 U.K. Monkeypox Vaccine and Treatment Market, By Gender, 2022 - 2030 (USD Million)
Table 33 U.K. Monkeypox Vaccine and Treatment Market, By Route of Administration, 2022 - 2030 (USD Million)
Table 34 U.K. Monkeypox Vaccine and Treatment Market, By End-use, 2022 - 2030 (USD Million)
Table 35 France Monkeypox Vaccine and Treatment Market, By Product, 2022 - 2030 (USD Million)
Table 36 France Monkeypox Vaccine and Treatment Market, By Gender, 2022 - 2030 (USD Million)
Table 37 France Monkeypox Vaccine and Treatment Market, By Route of Administration, 2022 - 2030 (USD Million)
Table 38 France Monkeypox Vaccine and Treatment Market, By End-use, 2022 - 2030 (USD Million)
Table 39 Italy Monkeypox Vaccine and Treatment Market, By Product, 2022 - 2030 (USD Million)
Table 40 Italy Monkeypox Vaccine and Treatment Market, By Gender, 2022 - 2030 (USD Million)
Table 41 Italy Monkeypox Vaccine and Treatment Market, By Route of Administration, 2022 - 2030 (USD Million)
Table 42 Italy Monkeypox Vaccine and Treatment Market, By End-use, 2022 - 2030 (USD Million)
Table 43 Spain Monkeypox Vaccine and Treatment Market, By Product, 2022 - 2030 (USD Million)
Table 44 Spain Monkeypox Vaccine and Treatment Market, By Gender, 2022 - 2030 (USD Million)
Table 45 Spain Monkeypox Vaccine and Treatment Market, By Route of Administration, 2022 - 2030 (USD Million)
Table 46 Spain Monkeypox Vaccine and Treatment Market, By End-use, 2022 - 2030 (USD Million)
Table 47 Asia Pacific Monkeypox Vaccine and Treatment Market, By Country, 2022 - 2030 (USD Million)
Table 48 Asia Pacific Monkeypox Vaccine and Treatment Market, By Product, 2022 - 2030 (USD Million)
Table 49 Asia Pacific Monkeypox Vaccine and Treatment Market, By Gender, 2022 - 2030 (USD Million)
Table 50 Asia Pacific Monkeypox Vaccine and Treatment Market, By Route of Administration, 2022 - 2030 (USD Million)
Table 51 Asia Pacific Monkeypox Vaccine and Treatment Market, By End-use, 2022 - 2030 (USD Million)
Table 52 Japan Monkeypox Vaccine and Treatment Market, By Product, 2022 - 2030 (USD Million)
Table 53 Japan Monkeypox Vaccine and Treatment Market, By Gender, 2022 - 2030 (USD Million)
Table 54 Japan Monkeypox Vaccine and Treatment Market, By Route of Administration, 2022 - 2030 (USD Million)
Table 55 Japan Monkeypox Vaccine and Treatment Market, By End-use, 2022 - 2030 (USD Million)
Table 56 China Monkeypox Vaccine and Treatment Market, By Product, 2022 - 2030 (USD Million)
Table 57 China Monkeypox Vaccine and Treatment Market, By Gender, 2022 - 2030 (USD Million)
Table 58 China Monkeypox Vaccine and Treatment Market, By Route of Administration, 2022 - 2030 (USD Million)
Table 59 China Monkeypox Vaccine and Treatment Market, By End-use, 2022 - 2030 (USD Million)
Table 60 India Monkeypox Vaccine and Treatment Market, By Product, 2022 - 2030 (USD Million)
Table 61 India Monkeypox Vaccine and Treatment Market, By Gender, 2022 - 2030 (USD Million)
Table 62 India Monkeypox Vaccine and Treatment Market, By Route of Administration, 2022 - 2030 (USD Million)
Table 63 India Monkeypox Vaccine and Treatment Market, By End-use, 2022 - 2030 (USD Million)
Table 64 South Korea Monkeypox Vaccine and Treatment Market, By Product, 2022 - 2030 (USD Million)
Table 65 South Korea Monkeypox Vaccine and Treatment Market, By Gender, 2022 - 2030 (USD Million)
Table 66 South Korea Monkeypox Vaccine and Treatment Market, By Route of Administration, 2022 - 2030 (USD Million)
Table 67 South Korea Monkeypox Vaccine and Treatment Market, By End-use, 2022 - 2030 (USD Million)
Table 68 Australia Monkeypox Vaccine and Treatment Market, By Product, 2022 - 2030 (USD Million)
Table 69 Australia Monkeypox Vaccine and Treatment Market, By Gender, 2022 - 2030 (USD Million)
Table 70 Australia Monkeypox Vaccine and Treatment Market, By Route of Administration, 2022 - 2030 (USD Million)
Table 71 Australia Monkeypox Vaccine and Treatment Market, By End-use, 2022 - 2030 (USD Million)
Table 72 Latin America Monkeypox Vaccine and Treatment Market, By Country, 2022 - 2030 (USD Million)
Table 73 Latin America Monkeypox Vaccine and Treatment Market, By Product, 2022 - 2030 (USD Million)
Table 74 Latin America Monkeypox Vaccine and Treatment Market, By Gender, 2022 - 2030 (USD Million)
Table 75 Latin America Monkeypox Vaccine and Treatment Market, By Route of Administration, 2022 - 2030 (USD Million)
Table 76 Latin America Monkeypox Vaccine and Treatment Market, By End-use, 2022 - 2030 (USD Million)
Table 77 Mexico Monkeypox Vaccine and Treatment Market, By Product, 2022 - 2030 (USD Million)
Table 78 Mexico Monkeypox Vaccine and Treatment Market, By Gender, 2022 - 2030 (USD Million)
Table 79 Mexico Monkeypox Vaccine and Treatment Market, By Route of Administration, 2022 - 2030 (USD Million)
Table 80 Mexico Monkeypox Vaccine and Treatment Market, By End-use, 2022 - 2030 (USD Million)
Table 81 Brazil Monkeypox Vaccine and Treatment Market, By Product, 2022 - 2030 (USD Million)
Table 82 Brazil Monkeypox Vaccine and Treatment Market, By Gender, 2022 - 2030 (USD Million)
Table 83 Brazil Monkeypox Vaccine and Treatment Market, By Route of Administration, 2022 - 2030 (USD Million)
Table 84 Brazil Monkeypox Vaccine and Treatment Market, By End-use, 2022 - 2030 (USD Million)
Table 85 Argentina Monkeypox Vaccine and Treatment Market, By Product, 2022 - 2030 (USD Million)
Table 86 Argentina Monkeypox Vaccine and Treatment Market, By Gender, 2022 - 2030 (USD Million)
Table 87 Argentina Monkeypox Vaccine and Treatment Market, By Route of Administration, 2022 - 2030 (USD Million)
Table 88 Argentina Monkeypox Vaccine and Treatment Market, By End-use, 2022 - 2030 (USD Million)
Table 89 Middle East and Africa Monkeypox Vaccine and Treatment Market, By Country, 2022 - 2030 (USD Million)
Table 90 Middle East and Africa Monkeypox Vaccine and Treatment Market, By Product, 2022 - 2030 (USD Million)
Table 91 Middle East and Africa Monkeypox Vaccine and Treatment Market, By Gender, 2022 - 2030 (USD Million)
Table 92 Middle East and Africa Monkeypox Vaccine and Treatment Market, By Route of Administration, 2022-203(USD Million)
Table 93 Middle East and Africa Monkeypox Vaccine and Treatment Market, By End-use, 2022 - 2030 (USD Million)
Table 94 South Africa Monkeypox Vaccine and Treatment Market, By Product, 2022 - 2030 (USD Million)
Table 95 South Africa Monkeypox Vaccine and Treatment Market, By Gender, 2022 - 2030 (USD Million)
Table 96 South Africa Monkeypox Vaccine and Treatment Market, By Route of Administration, 2022 - 2030 (USD Million)
Table 97 South Africa Monkeypox Vaccine and Treatment Market, By End-use, 2022 - 2030 (USD Million)
Table 98 Saudi Arabia Monkeypox Vaccine and Treatment Market, By Product, 2022 - 2030 (USD Million)
Table 99 Saudi Arabia Monkeypox Vaccine and Treatment Market, By Gender, 2022 - 2030 (USD Million)
Table 100 Saudi Arabia Monkeypox Vaccine and Treatment Market, By Route of Administration, 2022 - 2030 (USD Million)
Table 101 Saudi Arabia Monkeypox Vaccine and Treatment Market, By End-use, 2022 - 2030 (USD Million)
Table 102 UAE Monkeypox Vaccine and Treatment Market, By Product, 2022 - 2030 (USD Million)
Table 103 UAE Monkeypox Vaccine and Treatment Market, By Gender, 2022 - 2030 (USD Million)
Table 104 UAE Monkeypox Vaccine and Treatment Market, By Route of Administration, 2022 - 2030 (USD Million)
Table 105 UAE Monkeypox Vaccine and Treatment Market, By End-use, 2022 - 2030 (USD Million)
List of Figures
Fig. 1 Monkeypox vaccine and treatment market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Market outlook (2022)
Fig. 10 Strategy framework
Fig. 11 Market driver relevance analysis (Current & future impact)
Fig. 12 Market restraint relevance analysis (Current & future impact)
Fig. 13 Penetration & growth prospect mapping
Fig. 14 Porter’s five forces analysis
Fig. 15 PESTLE analysis
Fig. 16 Monkeypox vaccine and treatment market: Product movement analysis
Fig. 17 Monkeypox vaccine and treatment market: Product segment dashboard
Fig. 18 Monkeypox vaccine and treatment market product outlook: Key takeaways
Fig. 19 Vaccine market estimates and forecasts, 2022 - 2030 (USD Million)
Fig. 20 JYNNEOS/ Imvanex market estimates and forecasts, 2022 - 2030 (USD Million)
Fig. 21 Smallpox vaccine market estimates and forecasts, 2022 - 2030 (USD Million)
Fig. 22 Others market estimates and forecasts, 2022 - 2030 (USD Million)
Fig. 23 Drugs market estimates and forecasts, 2022 - 2030 (USD Million)
Fig. 24 Tecovirimat market estimates and forecasts, 2022 - 2030 (USD Million)
Fig. 25 Brincidofovir market estimates and forecasts, 2022 - 2030 (USD Million)
Fig. 26 Cidofovir market estimates and forecasts, 2022 - 2030 (USD Million)
Fig. 27 Others market estimates and forecasts, 2022 - 2030 (USD Million)
Fig. 28 Vaccinia Immune Globulin (VIG) market estimates and forecasts, 2022 - 2030 (USD Million)
Fig. 29 Monkeypox vaccine and treatment market: Gender analysis
Fig. 30 Monkeypox vaccine and treatment market: Gender segment dashboard
Fig. 31 Monkeypox vaccine and treatment market gender outlook: Key takeaways
Fig. 32 Male market estimates and forecasts, 2022 - 2030 (USD Million)
Fig. 33 Female market estimates and forecasts, 2022 - 2030 (USD Million)
Fig. 34 Others market estimates and forecasts, 2022 - 2030 (USD Million)
Fig. 35 Monkeypox vaccine and treatment market: Route of administration movement analysis
Fig. 36 Monkeypox vaccine and treatment market: Route of administration segment dashboard
Fig. 37 Monkeypox vaccine and treatment market, route of administration outlook: Key takeaways
Fig. 38 Oral market estimates and forecasts, 2022 - 2030 (USD Million)
Fig. 39 InjecTables market estimates and forecasts, 2022 - 2030 (USD Million)
Fig. 40 Monkeypox vaccine and treatment market: End-use movement analysis
Fig. 41 Monkeypox vaccine and treatment market: End-use segment dashboard
Fig. 42 Monkeypox vaccine and treatment market, end-use outlook: Key takeaways
Fig. 43 Hospitals market estimates and forecasts, 2022 - 2030 (USD Million)
Fig. 44 Specialty clinics market estimates and forecasts, 2022 - 2030 (USD Million)
Fig. 45 Others market estimates and forecasts, 2022 - 2030 (USD Million)
Fig. 46 Regional outlook estimates and forecasts, 2022 & 2030
Fig. 47 Regional market dashboard
Fig. 48 Regional marketplace: Key takeaways
Fig. 49 North America, SWOT
Fig. 50 Europe, SWOT
Fig. 51 Asia Pacific, SWOT
Fig. 52 Latin America, SWOT
Fig. 53 Middle East and Africa, SWOT
Fig. 54 North America
Fig. 55 North America monkeypox vaccine and treatment market, 2022 - 2030 (USD Million)
Fig. 56 U.S.
Fig. 57 U.S. monkeypox vaccine and treatment market, 2022 - 2030 (USD Million)
Fig. 58 Canada
Fig. 59 Canada monkeypox vaccine and treatment market, 2022 - 2030 (USD Million)
Fig. 60 Europe
Fig. 61 Europe monkeypox vaccine and treatment market, 2022 - 2030 (USD Million)
Fig. 62 U.K.
Fig. 63 U.K. monkeypox vaccine and treatment market, 2022 - 2030 (USD Million)
Fig. 64 Germany
Fig. 65 Germany monkeypox vaccine and treatment market, 2022 - 2030 (USD Million)
Fig. 66 Spain
Fig. 67 Spain monkeypox vaccine and treatment market, 2022 - 2030 (USD Million)
Fig. 68 France
Fig. 69 France monkeypox vaccine and treatment market, 2022 - 2030 (USD Million)
Fig. 70 Italy
Fig. 71 Italy monkeypox vaccine and treatment market, 2022 - 2030 (USD Million)
Fig. 72 Russia
Fig. 73 Russia monkeypox vaccine and treatment market, 2022 - 2030 (USD Million)
Fig. 74 Asia Pacific
Fig. 75 Asia Pacific monkeypox vaccine and treatment market, 2022 - 2030 (USD Million)
Fig. 76 Japan
Fig. 77 Japan monkeypox vaccine and treatment market, 2022 - 2030 (USD Million)
Fig. 78 China
Fig. 79 China monkeypox vaccine and treatment market, 2022 - 2030 (USD Million)
Fig. 80 India
Fig. 81 India monkeypox vaccine and treatment market, 2022 - 2030 (USD Million)
Fig. 82 South Korea
Fig. 83 South Korea monkeypox vaccine and treatment market, 2022 - 2030 (USD Million)
Fig. 84 Australia
Fig. 85 Australia monkeypox vaccine and treatment market, 2022 - 2030 (USD Million)
Fig. 86 Latin America
Fig. 87 Latin America monkeypox vaccine and treatment market, 2022 - 2030 (USD Million)
Fig. 88 Brazil
Fig. 89 Brazil monkeypox vaccine and treatment market, 2022 - 2030 (USD Million)
Fig. 90 Mexico
Fig. 91 Mexico monkeypox vaccine and treatment market, 2022 - 2030 (USD Million)
Fig. 92 Argentina
Fig. 93 Argentina monkeypox vaccine and treatment market, 2022 - 2030 (USD Million)
Fig. 94 Middle East and Africa
Fig. 95 MEA monkeypox vaccine and treatment market, 2022 - 2030 (USD Million)
Fig. 96 South Africa
Fig. 97 South Africa monkeypox vaccine and treatment market, 2022 - 2030 (USD Million)
Fig. 98 Saudi Arabia
Fig. 99 Saudi Arabia monkeypox vaccine and treatment market, 2022 - 2030 (USD Million)
Fig. 100 UAE
Fig. 101 UAE monkeypox vaccine and treatment market, 2022 - 2030 (USD Million)
Fig. 102 Ansoff Matrix
Fig. 103 Heat map analysis
Fig. 104 Market differentiators

Companies Mentioned

  • Bavarian Nordic
  • Siga Technologies
  • Chimerix
  • Emergent
  • Gilead Sciences, Inc.

Methodology

Loading
LOADING...

Related Topics

Related Reports

Monkeypox Vaccine and Treatment Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2030 - Product Image

Monkeypox Vaccine and Treatment Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2030

  • Report
  • 300 Pages
  • Global
From
mRNA Vaccine and Therapeutics - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

mRNA Vaccine and Therapeutics - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 100 Pages
  • Global
From
Herpes Simplex Virus Treatment Market Size, Share & Trends Analysis Report by Type (HSV-1, HSV-2), Drug (Acyclovir, Valacyclovir, Famciclovir), Vaccine (Simplirix, Others), Route of Administration, End-use, Region, and Segment Forecasts, 2024-2030 - Product Image

Herpes Simplex Virus Treatment Market Size, Share & Trends Analysis Report by Type (HSV-1, HSV-2), Drug (Acyclovir, Valacyclovir, Famciclovir), Vaccine (Simplirix, Others), Route of Administration, End-use, Region, and Segment Forecasts, 2024-2030

  • Report
  • 80 Pages
  • Global
From
Recombinant Vaccines Market Analysis & Forecast to 2024-2034 - Product Image

Recombinant Vaccines Market Analysis & Forecast to 2024-2034

  • Report
  • 200 Pages
  • Global
From
Influenza Vaccine Market Size, Share & Trends Analysis Report by Vaccine Type (Inactivated, Live Attenuated), Indication, Age Group, Route Of Administration, Distribution Channel, Region, and Segment Forecasts, 2024-2030 - Product Image

Influenza Vaccine Market Size, Share & Trends Analysis Report by Vaccine Type (Inactivated, Live Attenuated), Indication, Age Group, Route Of Administration, Distribution Channel, Region, and Segment Forecasts, 2024-2030

  • Report
  • 150 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.